Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 10—October 2005

Melioidosis in Tsunami Survivors

Eugene Athan*Comments to Author , Anthony M. Allworth†, Catherine Engler‡, Ivan Bastian§, and Allen C. Cheng*¶
Author affiliations: *The Geelong Hospital, Geelong, Victoria, Australia; †Royal Brisbane Hospital, Brisbane, Queensland, Australia; ‡Queensland Health Pathology Services, Townsville, Queensland, Australia; §Institute of Medical and Veterinary Science, Adelaide, South Australia, Australia; ¶Menzies School of Health Research, Darwin, Northern Territory, Australia

Main Article


Clinical details of pneumonia patients after tsunami in Banda Aceh, Indonesia, January 2003*

Patient no. Age (y)/sex Radiograph results Complications Microbiologic test results Days before treatment Antimicrobial drug Acute outcome
1 7/M Bilateral infiltrates Cavitation No cultures taken 19 Meropenem Fever resolved, improving @30 days
2 12/M Bilateral infiltrates Pseudomonas aeruginosa (sputum) 37 Meropenem Serious but stable @12 days
3 5/M Unilateral infiltrates Cavitation No cultures taken 10 Meropenem Fever resolved, improving @39 days
4 15/F Bilateral infiltrates Pneumothorax, empyema Burkholderia pseudomallei (sputum) 27 Meropenem 2 wks, then oral TMP-SMX and coamoxiclav Fully recovered, discharged @20 days
5 14/M Bilateral infiltrates P. aeruginosa (sputum) 35 Meropenem Improving @11 days
6 6/M Bilateral infiltrates P. aeruginosa (sputum) 30 Meropenem Improving @19 days
7 18 mo/M Bilateral infiltrates Empyema B. pseudomallei (pleural fluid) 30 Meropenem Improving @23 days
8 10/F Bilateral infiltrates Empyema P. aeruginosaB. pseudomalleiKlebsiella sp. (pleural fluid) 30 Meropenem Improving @23 days
9 13/F Bilateral infiltrates P. aeruginosaB. pseudomallei (sputum) 33 Meropenem Improving @18 days
10 17/F Unknown Unknown Nocardia spp. (sputum) 21 Ticarcillin/clavulanate, ciprofloxacin Not improving, outcome unknown @12 days

*ICU, intensive care unit; TMP-SMX, trimethoprim-sulfamethoxazole.

Main Article

Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.